←Back to Expert Scholars
Translational Medicine / 转化医学Ki67 & Proliferation
Erica Mayer
MD, MPH
🏢Dana-Farber Cancer Institute🌐USA
Senior Physician, Breast Oncology
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Erica Mayer is a breast oncologist at Dana-Farber known for adjuvant endocrine therapy and extended treatment trials. She has investigated Ki67 response as an intermediate endpoint in extended therapy studies. Her research informs survivorship-integrated adjuvant treatment decisions.
Share:
🧪Research Fields 研究领域
Adjuvant endocrine therapy
Extended therapy trials
CDK4/6 inhibitors
Breast cancer survivorship
Clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Erica Mayer 的研究动态
Follow Erica Mayer's research updates
留下邮箱，当我们发布与 Erica Mayer（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment